Avolio, Alfonso Wolfango
 Distribuzione geografica
Continente #
EU - Europa 4.445
NA - Nord America 4.162
AS - Asia 1.605
AF - Africa 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 10.253
Nazione #
US - Stati Uniti d'America 4.093
DE - Germania 1.402
SE - Svezia 873
CN - Cina 842
UA - Ucraina 523
IT - Italia 455
SG - Singapore 373
IE - Irlanda 257
FR - Francia 235
GB - Regno Unito 208
PL - Polonia 148
ID - Indonesia 141
FI - Finlandia 137
RU - Federazione Russa 73
TR - Turchia 67
IN - India 61
CA - Canada 53
BE - Belgio 43
HK - Hong Kong 30
IR - Iran 26
KR - Corea 22
JP - Giappone 20
LT - Lituania 14
MX - Messico 13
NL - Olanda 13
RO - Romania 12
ES - Italia 11
EU - Europa 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
AU - Australia 7
BR - Brasile 6
VN - Vietnam 6
CI - Costa d'Avorio 5
AT - Austria 4
BG - Bulgaria 4
EE - Estonia 4
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
PT - Portogallo 3
TH - Thailandia 3
MD - Moldavia 2
MU - Mauritius 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 10.253
Città #
Chandler 770
Ashburn 415
Jacksonville 285
Singapore 275
Dublin 249
San Mateo 235
Ann Arbor 177
Nanjing 153
Jakarta 139
Wilmington 119
Munich 107
Boston 106
Beijing 102
Warsaw 97
Marseille 96
New York 91
Woodbridge 89
Rome 87
Mcallen 83
Lawrence 82
Seattle 80
Dearborn 77
Nürnberg 72
Bremen 68
Redwood City 68
Houston 67
Fairfield 64
Nanchang 61
Izmir 57
Milan 56
Moscow 52
Shenyang 52
Cattolica 49
Princeton 47
Hangzhou 45
Hebei 42
Chicago 41
Helsinki 41
University Park 41
Zhengzhou 40
Brussels 39
Lancaster 36
Andover 33
Tianjin 31
Kraków 30
Mountain View 28
Kunming 27
Changsha 25
Augusta 24
Montréal 24
Guangzhou 22
Hong Kong 22
Norwalk 22
Shanghai 22
Jiaxing 19
London 18
Chengdu 17
Fremont 17
Hounslow 17
Kish 17
Los Angeles 17
Ningbo 17
Pune 16
Cambridge 15
Detroit 15
Boardman 14
Frankfurt am Main 13
Jinan 12
Toronto 12
San Giovanni Bianco 11
Leawood 9
Seongnam 9
Hefei 8
San Diego 8
Santa Clara 8
Segrate 8
Changchun 7
Falls Church 7
Redmond 7
Seoul 7
Timisoara 7
Washington 7
Ardabil 6
Lanzhou 6
Madrid 6
Mexico City 6
Ottawa 6
Paris 6
Santa Maria 6
Taizhou 6
Ypsilanti 6
Abidjan 5
Berlin 5
Brno 5
Buffalo 5
Falkenstein 5
Padova 5
Wuhan 5
Antwerpen 4
Brescia 4
Totale 5.698
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 352
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 298
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 218
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 164
Duplex Doppler in the postoperative monitoring of liver transplant recipients 160
Accidental transplantation of a kidney with stones: case report 155
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 153
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 145
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 142
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 139
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 137
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 136
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 118
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 118
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 112
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 112
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 111
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 107
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 106
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 106
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 105
Model for end-stage liver disease dynamic stratification of survival benefit 104
Prediction of 6-month survival after liver transplantation using Cox regression. 103
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 103
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 102
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 100
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 100
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 95
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 94
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 94
Psychological risk factors for graft rejection among liver transplant recipients 94
Liver transplantation in patients with alcoholic liver disease: A retrospective study 93
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 92
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 92
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 92
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 90
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 90
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 90
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 85
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 85
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 84
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 83
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 82
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 81
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 81
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 79
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 79
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 79
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 77
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 77
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 76
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 75
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 74
Primary difunction after liver trasplantation: donor or recipients fault? 72
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 72
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 72
Clinical problems of the transplanted kidney 71
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 71
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 70
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 70
Is primary nonfunction still a suitable indication for liver retransplantation? 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 70
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 69
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 69
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 69
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 69
Celiac axis compression syndrome in liver transplantation 68
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 68
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 68
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 66
Balancing Utility and Need by Means of Donor-to-Recipient Matching: A Challenging Problem. 65
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 65
Cefotetan versus cefoxitin in peritonitis 64
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 64
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 63
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 63
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 62
Should retransplantation still be considered for primary non-function after liver transplantation? 62
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 61
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 61
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 61
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 60
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 59
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 59
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 57
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 57
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 57
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 56
Marginal donors for patients on regular waiting lists for liver transplantation 55
Recovery index: a useful tool for quantification of liver injury after liver transplantation to predict one-year survival 55
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 54
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients 54
Outcome of liver transplatation after acute rejection and sepsis 53
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 53
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 53
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 51
Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection 51
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 51
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 50
Totale 8.949
Categoria #
all - tutte 44.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020832 0 0 0 0 0 160 186 64 86 98 124 114
2020/20211.111 81 114 14 112 169 50 114 19 132 71 212 23
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/2025703 45 61 199 95 202 101 0 0 0 0 0 0
Totale 10.369